Meet the start-ups taking the stage at Pitch & Pour: Start-Up Pitch Competition! On Sunday, October 18 from 3:00-5:30 PM, 12 early-stage companies will pitch their innovations in military health to a room of investors, strategics and industry decision-makers during this high-energy happy hour competition at The MedTech Conference.
Each start-up will have just 8 minutes to make their case, with a 5-minute pitch followed by 3 minutes of Q&A. Get to know this year’s competitors below, then join us in Boston October 18-21 to see who takes home the win.
Thank you to our Pitch & Pour sponsors: Maryland Department of Commerce, Medmarc, and MTEC.
Meet the Innovators Taking the Stage
| ARMR Systems, Inc. ARMR is redefining hemorrhage control by bringing advanced, wearable trauma care to patients when medical support may not be immediately available. Its JT5 is a lightweight, tourniquet-style direct pressure device designed to rapidly compress damaged arteries in critical torso-junctional areas that traditional tourniquets cannot reach. By making advanced hemorrhage control more accessible and less dependent on immediate medic intervention, ARMR aims to improve survivability when every second counts. |
| BLASTID BLASTID is transforming bloodstream infection diagnosis by delivering actionable pathogen identification and antimicrobial susceptibility testing (AST) directly from whole blood within hours instead of days. Its SPLENDID™ platform is designed to bypass the culture-dependent bottleneck by isolating viable pathogens directly from a single blood draw and enabling rapid identification and phenotypic AST. By helping clinicians move from empirical treatment to targeted therapy sooner, BLASTID aims to improve patient outcomes, reduce unnecessary antibiotic use, and combat antimicrobial resistance. |
| CranioSense CranioSense is developing the first non-invasive medical device designed to rapidly and accurately diagnose intracranial hypertension. Today, measuring intracranial pressure typically requires an invasive procedure, creating challenges in diagnosing this life-threatening condition and its risk of secondary brain injury across conditions including traumatic brain injury, hydrocephalus, and idiopathic intracranial hypertension. CranioSense aims to give clinicians a faster, safer way to identify intracranial hypertension and improve diagnosis in the emergency department. |
| GenAssist GenAssist is developing biomaterials designed to regenerate and restore skeletal muscle after severe trauma. Today, up to 50% of patients with severe muscle injuries experience permanent disability because existing treatments cannot replace lost muscle tissue or restore function. GenAssist’s MyoSponge® is designed to restore contractile muscle tissue within the defect, offering surgeons a new approach to reducing the lasting physical, financial, and psychological burden of severe muscle trauma. |
| Halite Medical Halite Medical is helping clinicians spend less time documenting care and more time delivering it when every second counts. Its STRATA platform combines hands-free, offline-first documentation with predictive clinical intelligence, with Triage Scribe capturing TCCC and DD Form 1380 documentation as medics speak and APPRAISE-HRI detecting signs of hemorrhagic deterioration before vital signs change. Designed for use from point of injury through evacuation and prolonged field care, STRATA helps clinicians act earlier while creating a more complete record of care. |
| MedCu Technologies, LTD. MedCu is bringing the biological power of copper to point-of-injury wound care, with technology designed to improve survival and recovery in military trauma. Its FDA- and CE-cleared family of copper wound dressings combines broad-spectrum antimicrobial and anti-biofilm protection with support for wound healing, addressing limitations of conventional field dressings that primarily stop bleeding or cover the wound. Already moving into military use, MedCu is developing next-generation copper dressings designed to combine hemorrhage control, infection prevention, and active healing for combat casualty care and prolonged-field care. |
| Noxsano, Inc. Noxsano is developing wound care technology designed to deliver active, regenerative healing across even the most challenging wounds. Its nitric oxide generation system continuously delivers biologically relevant levels of nitric oxide for up to 7 days, helping prevent and treat infection while supporting tissue repair, with products that can be stored dry and activated with water or blood. Designed for lightweight, extended use in austere environments, Noxsano’s technology could provide frontline wound care that combines infection control and healing when evacuation and frequent dressing changes are not feasible. |
| Omedus Omedus is transforming emergency triage with technology designed to help responders rapidly assess, prioritize, and monitor patients when every second counts. Its Triage360 platform combines wearable sensors with a real-time dashboard to help medics identify life-threatening conditions, prioritize treatment and evacuation, and maintain visibility across the casualty care chain. Designed for both civilian and military environments, Triage360 reduces cognitive burden and supports faster, more informed decision-making in chaotic, resource-limited settings. |
| Plas-Free Plas-Free is developing plasma technology designed to improve bleeding control and save lives when hemorrhage is life-threatening. Its flagship ClearPlasma™ technology enhances the hemostatic performance of donor plasma by selectively removing key drivers of excessive clot breakdown, without requiring changes to existing transfusion workflows or specialized equipment. With applications spanning combat trauma, prehospital care, surgery, and prolonged field care, ClearPlasma™ has the potential to improve survival, reduce blood product use, and accelerate stabilization when every second matters. |
| RBT Resources, Inc. RBT Resources is developing next-generation blood transfusion technology designed to deliver life-saving whole blood faster when every second matters. Its Combat Rapid Blood Transfusion (CRBT) device is designed to cut transfusion time to under 5 minutes, a 75% reduction, with a lightweight, field-ready pump supporting rapid blood delivery at the point of injury. Founded by former U.S. Special Operations operators and shaped through collaboration with military medical teams, RBT is developing compact, reusable systems for combat, austere, and mass-casualty environments. |
| SafeBVM SafeBVM is transforming manual ventilation with technology designed to make every breath safer, more controlled, and measurable. Its FDA-cleared and Health Canada–licensed Sotair® device moderates peak inspiratory flow, helping providers deliver more consistent ventilation without power, screens, or capital equipment, while SotairIQ™ provides real-time feedback on flow, pressure, tidal volume, rate, and inspiratory time. With applications across EMS, hospitals, military medicine, and austere care, SafeBVM is turning manual ventilation from a procedure delivered largely by feel into one guided by objective data. |
| Surgicure Technologies, Inc Surgicure Technologies is building a commercialization platform designed to turn military medical breakthroughs into the next generation of civilian and battlefield care. While billions are invested in military medical R&D, many validated technologies never reach patients because they lack a path to licensing, regulatory approval, manufacturing, or distribution. Surgicure bridges that gap by identifying high-potential government technologies, validating them with military and civilian clinicians, and advancing selected solutions through commercialization, with its HORSESHOE™ airway security device serving as the first proof point. |
Don’t miss the chance to see these emerging companies take the stage and connect with the innovators shaping the future of military health. Join us Sunday, October 18, for Pitch & Pour before the Global Medtech Welcome Reception, and see which start-up rises to the top.